GK
Insider
George Kemble
Executive ChairmanGeorge Kemble (Executive Chairman) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Sagimet Biosciences Inc. (SGMT). The largest single filing was $3.6M of SGMT (350,987 sh × $10.23, as filed), executed Aug 14.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.2M
shares × price, as filed
Last traded
Aug 14
Filed Aug 17
Median ADV $12.5M across their filed names
Open performance→Volume by month
Buys $0
Sells $4.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Sector per market data · by filing · past 12 months
Most traded names
SGMTRecent filings
SGMTSALE
Sagimet Biosciences Inc.
View filing →
$3.6M350,987 sh × $10.23
Exec Aug 14
Filed Aug 17 · 4:05 PM ET SGMTSALE Sagimet Biosciences Inc. View filing → $201K
20,206 sh × $9.95
Exec Aug 11
Filed Aug 12 · 7:41 PM ET SGMTSALE Sagimet Biosciences Inc. View filing → $141K
18,844 sh × $7.46
Exec Jul 20
Filed Jul 22 · 4:05 PM ET SGMTSALE Sagimet Biosciences Inc. View filing → $290K
37,688 sh × $7.69
Exec Nov 20 2025
Filed Nov 21 2025 · 5:30 PM ET